Immediate Impact
1 from Science/Nature 56 standout
Citing Papers
The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
2025 Standout
Effective extracellular payload release and immunomodulatory interactions govern the therapeutic effect of trastuzumab deruxtecan (T-DXd)
2025 Standout
Works of Xiangfeng Shen being referenced
Recent Findings in the Regulation of Programmed Death Ligand 1 Expression
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Xiangfeng Shen | 195 | 134 | 39 | 68 | 18 | 499 | |
| Shanyan Chen | 205 | 41 | 17 | 78 | 29 | 504 | |
| Guoliang Jin | 261 | 126 | 52 | 54 | 25 | 561 | |
| Wei Zhang | 105 | 46 | 9 | 27 | 18 | 412 | |
| Yu Shen | 119 | 35 | 20 | 48 | 25 | 453 | |
| Daisuke Hayashi | 149 | 25 | 25 | 28 | 33 | 438 | |
| Lingfei Li | 206 | 31 | 31 | 54 | 25 | 574 | |
| Jeong Ho Han | 137 | 51 | 17 | 18 | 27 | 466 | |
| Emily A. Caseley | 235 | 11 | 15 | 14 | 19 | 487 | |
| Wenyu Zhu | 196 | 52 | 9 | 85 | 22 | 445 | |
| Pengfei Yang | 130 | 36 | 46 | 32 | 30 | 490 |
All Works
Loading papers...